Cargando…

Survival trends in hematological malignancies in the Nordic countries through 50 years

[Image: see text]

Detalles Bibliográficos
Autores principales:	Hemminki, Kari, Hemminki, Janne, Försti, Asta, Sud, Amit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637692/ https://www.ncbi.nlm.nih.gov/pubmed/36336699 http://dx.doi.org/10.1038/s41408-022-00728-z

Ejemplares similares

Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment
por: Hemminki, Kari, et al.
Publicado: (2023)

Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic Countries
por: Tichanek, Filip, et al.
Publicado: (2023)

Long-term survival trends for primary liver and pancreatic cancers in the Nordic countries
por: Hemminki, Kari, et al.
Publicado: (2022)

Incidence, Mortality and Survival Trends in Breast Cancers Coincident with Introduction of Mammography in the Nordic Countries
por: Hemminki, Kari, et al.
Publicado: (2022)

Conditional survival in breast cancer up to 10 years in the Nordic countries
por: Zitricky, Frantisek, et al.
Publicado: (2023)

Survival in Lung Cancer in the Nordic Countries Through A Half Century
por: Tichanek, Filip, et al.
Publicado: (2023)

Survival in gastric and esophageal cancers in the Nordic countries through a half century
por: Hemminki, Kari, et al.
Publicado: (2023)

Survival in melanoma in the nordic countries into the era of targeted and immunological therapies
por: Tichanek, Filip, et al.
Publicado: (2023)

Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century
por: Tichanek, Filip, et al.
Publicado: (2023)

Long-Term Periodic and Conditional Survival Trends in Prostate, Testicular, and Penile Cancers in the Nordic Countries, Marking Timing of Improvements
por: Tichanek, Filip, et al.
Publicado: (2023)

Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements
por: Zitricky, Frantisek, et al.
Publicado: (2023)

Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century
por: Tichanek, Filip, et al.
Publicado: (2023)

Survival in colon and rectal cancers in Finland and Sweden through 50 years
por: Hemminki, Kari, et al.
Publicado: (2021)

Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden
por: Hemminki, Kari, et al.
Publicado: (2021)

Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years
por: Hemminki, Kari, et al.
Publicado: (2022)

Types of second primary cancers influence survival in chronic lymphocytic and hairy cell leukemia patients
por: Zheng, Guoqiao, et al.
Publicado: (2019)

Multiple myeloma: family history and mortality in second primary cancers
por: Chattopadhyay, Subhayan, et al.
Publicado: (2018)

Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment
por: Hemminki, Kari, et al.
Publicado: (2022)

Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden
por: Hemminki, Kari, et al.
Publicado: (2021)

Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half century
por: Koskinen, Anni, et al.
Publicado: (2022)

Incidence and survival in oral and pharyngeal cancers in Finland and Sweden through half century
por: Koskinen, Anni I., et al.
Publicado: (2022)

Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016
por: Hemminki, Kari, et al.
Publicado: (2021)

Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor
por: Hemminki, Kari, et al.
Publicado: (2021)

Second Primary Cancers in Melanoma Patients Critically Shorten Survival
por: Zheng, Guoqiao, et al.
Publicado: (2020)

Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country
por: Hemminki, Kari, et al.
Publicado: (2022)

Types of second primary cancer influence overall survival in cutaneous melanoma
por: Zheng, Guoqiao, et al.
Publicado: (2021)

Incidence and survival in non-hereditary amyloidosis in Sweden
por: Hemminki, Kari, et al.
Publicado: (2012)

Systematic enrichment analysis of gene expression profiling studies identifies consensus pathways implicated in colorectal cancer development
por: Lascorz, Jesús, et al.
Publicado: (2011)

Consensus Pathways Implicated in Prognosis of Colorectal Cancer Identified Through Systematic Enrichment Analysis of Gene Expression Profiling Studies
por: Lascorz, Jesús, et al.
Publicado: (2011)

Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma
por: Hemminki, Kari, et al.
Publicado: (2012)

The ‘Common Disease-Common Variant’ Hypothesis and Familial Risks
por: Hemminki, Kari, et al.
Publicado: (2008)

Single nucleotide polymorphisms (SNPs) are inherited from parents and they measure heritable events
por: Hemminki, Kari, et al.
Publicado: (2005)

Familial risks for gallstones in the population of Sweden
por: Hemminki, Kari, et al.
Publicado: (2017)

Familial Risks Between Urolithiasis and Cancer
por: Hemminki, Kari, et al.
Publicado: (2018)

Familial Associations in Testicular Cancer with Other Cancers
por: Zhang, Luyao, et al.
Publicado: (2018)

Second primary cancer after female breast cancer: Familial risks and cause of death
por: Zheng, Guoqiao, et al.
Publicado: (2018)

Familial Risks and Mortality in Second Primary Cancers in Melanoma
por: Chattopadhyay, Subhayan, et al.
Publicado: (2019)

Prostate cancer survivors: Risk and mortality in second primary cancers
por: Chattopadhyay, Subhayan, et al.
Publicado: (2018)

Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example Urolithiasis
por: Hemminki, Kari, et al.
Publicado: (2017)

Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor
por: Zheng, Guoqiao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_chjfetkqvksagdqb6hc3n123o0